Purchase of prolacta breastmilk products (+6) for premature infants in the neonatal intensive care unit at tripler army medical center.
Ended Awarded
- Contract number
- HT009026FG1170007
- Awardee
-
Prolacta Bioscience, Inc. UEI VJUKD4ELEKD6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,972
Award facts
- Contract value 100% obligated
- $24,971.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- City of Industry, CA 91746, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $24,971.50 firm fixed price Blanket Purchase Agreement (BPA) call contract to Prolacta Bioscience, Inc. on November 10, 2025, for the purchase of Prolacta breastmilk products and related nutritional supplements for premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. The contract carries no set-aside designation and is scheduled for completion by September 30, 2026. Prolacta Bioscience, a for-profit manufacturer based in City of Industry, California, specializes in human milk-based nutritional products designed specifically for extremely low birth weight and critically ill neonates requiring intensive care.
This award represents a task order issued against one of Prolacta Bioscience's existing Indefinite Delivery Vehicles with the Defense Health Agency, which collectively total $4.15 million across three separate BPAs established between October 2022 and December 2024. The company's specialized portfolio includes pasteurized human milk fortifiers, donor human milk products, nutritional supplements, and pre-natal infant formulas—all critical components of neonatal intensive care. Prolacta Bioscience's exclusive federal contracting history with the Defense Health Agency underscores the company's position as a sole-source provider of these specialized human milk-based products throughout the military healthcare system.
Quick answers
Who was awarded contract HT009026FG1170007?
HT009026FG1170007 was awarded to Prolacta Bioscience, Inc. by Defense Health Agency (Department of Defense) on November 10, 2025.
How much is contract HT009026FG1170007 worth?
The government has obligated $24,972 on HT009026FG1170007.
Is contract HT009026FG1170007 an order under another contract?
Yes. HT009026FG1170007 is a BPA call under W81K0222A0010, a blanket purchase agreement.
Was contract HT009026FG1170007 competed?
The extent of competition for HT009026FG1170007 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award